JCM
CTSO icon

Jacobi Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Jacobi Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$1K – 1369
2020
Q4 		$1K Buy
+100
New +$837 ﹤0.01% 1215
2016
Q4 		– Sell
-5,000
Closed -$33K – 626
2016
Q3 		$33K Hold
5,000
– – 0.02% 303
2016
Q2 		$23K Buy
+5,000
New +$21.8K 0.01% 325

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobi Capital Management's CTSO Position: Q1 2021 in Review

Jacobi Capital Management sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 100 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in CTSO in Q2 2016 and held it in 3 quarters. The position peaked at $33K in Q3 2016. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

  • Jacobi Capital Management reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 100 Cytosorbents Corp shares in Q1 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in Cytosorbents Corp in Q2 2016 and held it in 3 quarters.
  • Jacobi Capital Management's Cytosorbents Corp position peaked at $33K in Q3 2016.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Jacobi Capital Management's 13F filing for Q1 2021, filed 11 May 2021.